EP3768094A4 - Capsules à enveloppe molle entériques - Google Patents

Capsules à enveloppe molle entériques Download PDF

Info

Publication number
EP3768094A4
EP3768094A4 EP19768554.8A EP19768554A EP3768094A4 EP 3768094 A4 EP3768094 A4 EP 3768094A4 EP 19768554 A EP19768554 A EP 19768554A EP 3768094 A4 EP3768094 A4 EP 3768094A4
Authority
EP
European Patent Office
Prior art keywords
softshell
enteric
capsules
softshell capsules
enteric softshell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP19768554.8A
Other languages
German (de)
English (en)
Other versions
EP3768094A1 (fr
EP3768094B1 (fr
EP3768094C0 (fr
Inventor
Toshikazu OKAYAMA
Miyako Takahashi
Takuma Fujii
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RP Scherer Technologies LLC
Original Assignee
RP Scherer Technologies LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RP Scherer Technologies LLC filed Critical RP Scherer Technologies LLC
Publication of EP3768094A1 publication Critical patent/EP3768094A1/fr
Publication of EP3768094A4 publication Critical patent/EP3768094A4/fr
Application granted granted Critical
Publication of EP3768094B1 publication Critical patent/EP3768094B1/fr
Publication of EP3768094C0 publication Critical patent/EP3768094C0/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP19768554.8A 2018-03-15 2019-03-15 Capsules à enveloppe molle entériques Active EP3768094B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862643521P 2018-03-15 2018-03-15
PCT/US2019/022411 WO2019178444A1 (fr) 2018-03-15 2019-03-15 Capsules à enveloppe molle entériques

Publications (4)

Publication Number Publication Date
EP3768094A1 EP3768094A1 (fr) 2021-01-27
EP3768094A4 true EP3768094A4 (fr) 2022-03-02
EP3768094B1 EP3768094B1 (fr) 2024-05-01
EP3768094C0 EP3768094C0 (fr) 2024-05-01

Family

ID=67907228

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19768554.8A Active EP3768094B1 (fr) 2018-03-15 2019-03-15 Capsules à enveloppe molle entériques

Country Status (14)

Country Link
US (1) US11980691B2 (fr)
EP (1) EP3768094B1 (fr)
JP (1) JP7303221B2 (fr)
CN (1) CN111867399B (fr)
AR (1) AR115269A1 (fr)
AU (1) AU2019236217B2 (fr)
CA (1) CA3091686A1 (fr)
IL (1) IL276942B2 (fr)
MX (1) MX2020008650A (fr)
MY (1) MY202587A (fr)
PH (1) PH12020500621A1 (fr)
SG (1) SG11202008715WA (fr)
WO (1) WO2019178444A1 (fr)
ZA (1) ZA202005153B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6887456B2 (ja) 2018-07-04 2021-06-16 キャプシュゲル・ベルジウム・エヌ・ヴィ 白色化剤として界面活性剤又は界面活性剤と塩を含有する皮膜形成性組成物
ES2932753T3 (es) * 2019-06-12 2023-01-25 Capsugel Belgium Nv Película, cápsula y composición filmógena que comprende una sal soluble en agua como agente opacificante
US20220400724A1 (en) * 2019-10-28 2022-12-22 R.P. Scherer Technologies, Llc Delayed release softgel capsules in higher ph environment
CA3197516A1 (fr) * 2020-11-11 2022-05-19 Karunakar Sukuru Capsules molles a liberation retardee
CA3119012C (fr) * 2021-05-18 2023-10-17 Gelentroceutics Inc. Formulation de capsules molles a base de gelatine et vegetariennes intrinsequement resistantes aux acides pour les produits pharmaceutiques/nutraceutiques
WO2023148204A1 (fr) * 2022-02-03 2023-08-10 Société des Produits Nestlé S.A. Forme posologique orale avec enveloppe de capsule gastro-résistante

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130259933A1 (en) * 2012-03-30 2013-10-03 Morishita Jintan Co., Ltd. Capsule which disintegrates specifically in the large intestine
EP3205339A1 (fr) * 2014-10-06 2017-08-16 Fuji Capsule Co., Ltd. Procédé de production de capsules molles sans raccord à enrobage entérique

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1176369A (ja) 1997-09-12 1999-03-23 Sansho Iyaku Kk 腸溶性軟カプセル
ES2258988T3 (es) 1999-12-22 2006-09-16 Pharmacia Corporation Composiciones de liberacion dual de un inhibidor de la ciclooxigenasa-2.
KR100379674B1 (ko) 2000-03-06 2003-04-10 주식회사 서흥캅셀 펙틴과 글리세린의 배합용액을 이용한 셀룰로오스 캅셀 및그의 제조방법
EP1184033A1 (fr) * 2000-09-01 2002-03-06 Warner-Lambert Company Compositions filmogènes à base de pectine
EP1490029A4 (fr) 2002-03-22 2006-02-22 Ranbaxy Lab Ltd Systeme d'administration de medicaments a liberation controlee de pravastatine
DK1545475T3 (da) 2002-10-01 2014-07-28 Banner Pharmacaps Inc Enterisk sammensætning til fremstillingen af blød kapselvæg
JP2004217566A (ja) 2003-01-15 2004-08-05 Kyowa Hakko Kogyo Co Ltd 製剤のゲル強度の増強方法および徐放性製剤
JP4359089B2 (ja) 2003-07-04 2009-11-04 株式会社富士通エフサス 鉱物資源の生産高算出方法及びシステム
JPWO2005025609A1 (ja) 2003-09-10 2007-11-08 株式会社Ｎｒｌファーマ ラクトフェリン素材組成物
WO2005053727A2 (fr) 2003-11-29 2005-06-16 Sangstat Medical Corporation Compositions pharmaceutiques pour agents peptidiques bioactifs
CN1929825A (zh) * 2004-01-20 2007-03-14 施泰福大药厂有限公司 皮肤病学的软凝胶组合物
JP2006082824A (ja) 2004-09-15 2006-03-30 Seiko Epson Corp 電子部品の包装方法及び包装体
US20060240108A1 (en) 2005-04-26 2006-10-26 Bernard Bobby L Cellulosic films incorporating a pharmaceutically acceptable plasticizer with enhanced wettability
US20070082046A1 (en) 2005-10-11 2007-04-12 Banner Pharmacaps, Inc. Enteric valproic acid
JP2007161694A (ja) 2005-12-09 2007-06-28 Toyo Seiyaku Kasei Kk ベンズイミダゾール系化合物を含有する安定化された経口用組成物
MX306461B (es) * 2006-06-05 2013-01-07 Ocean Nutrition Canada Ltd Microcapsulas con cubiertas mejoradas
JP5183104B2 (ja) 2006-06-19 2013-04-17 森下仁丹株式会社 口臭除去用多重ソフトカプセル
EP2073643A2 (fr) 2006-10-18 2009-07-01 DSMIP Assets B.V. Encapsulation de substances sensibles à la chaleur et à l'humidité
JP2009116382A (ja) 2007-11-01 2009-05-28 Hitachi Ltd 分散システム及び分散システムを有するコンピュータ
JP4971298B2 (ja) 2008-01-11 2012-07-11 ユニメディカル株式会社 腸溶性・徐放性ソフトカプセル及びその製造方法
JP5487379B2 (ja) 2008-03-19 2014-05-07 森下仁丹株式会社 血中リン濃度上昇抑制剤
JP4252619B1 (ja) * 2008-08-25 2009-04-08 中日本カプセル 株式会社 腸溶性ソフトカプセルの製造方法及び腸溶性ソフトカプセル
US20100062057A1 (en) 2008-09-10 2010-03-11 Pronova BioPharma Norge AS. Formulation
US8309107B2 (en) 2008-10-06 2012-11-13 Banner Pharmacaps, Inc. Stable solutions of orlistat for pharmaceutical dosage forms
EP2370059A1 (fr) 2008-11-28 2011-10-05 Novo Nordisk A/S Compositions pharmaceutiques appropriées pour une administration orale de dérivé de peptide d'insuline
WO2010117873A2 (fr) 2009-04-06 2010-10-14 Banner Pharmacaps, Inc. Solutions de progestérone à plus grande biodisponibilité
ES2530049T3 (es) * 2009-05-18 2015-02-26 Sigmoid Pharma Limited Composición que comprende gotas de aceite
KR101188746B1 (ko) 2009-09-23 2012-10-11 주식회사파마킹 에스-알릴-엘-시스테인을 유효성분으로 포함하는 위장질환 예방 또는 치료용 조성물
US9370493B2 (en) 2009-10-23 2016-06-21 Pronova Biopharma Norge As Coated capsules and tablets of a fatty acid oil mixture
ES2363964B1 (es) 2009-11-20 2012-08-22 Gp Pharm, S.A. Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados.
JP5675839B2 (ja) 2009-12-28 2015-02-25 リン ペイスーLING, Peixue ヒマワリ抽出物を含む医薬組成物、その調製方法及び使用
US20130115285A1 (en) 2010-02-12 2013-05-09 Eric H. Van Ness Enteric coating compositions and methods of making and using the same
ES2385240B1 (es) 2010-07-26 2013-09-23 Gp-Pharm, S.A. Cápsulas de principios activos farmacéuticos y ácidos grasos poliinsaturados para el tratamiento de enfermedades de la próstata.
US20120301546A1 (en) 2011-05-26 2012-11-29 Hassan Emadeldin M Acid-resistant soft gel compositions
WO2013043985A1 (fr) 2011-09-23 2013-03-28 The Regents Of The University Of California Huiles comestibles favorisant l'administration de stéroïdes administrés par voie orale
JP2013095750A (ja) 2011-11-04 2013-05-20 Yoshikazu Hatori 口腔内殺菌用ソフトカプセル
AU2013204592A1 (en) 2012-04-09 2013-10-24 QRxPharma Ltd. Controlled release formulations of opioids
US20130280323A1 (en) 2012-04-13 2013-10-24 Banner Pharmacaps, Inc. Soft Elastic Capsules Containing Tablets and Liquid or Semisolid Fills and Methods for Their Manufacture
JP5907796B2 (ja) 2012-04-26 2016-04-26 日清ファルマ株式会社 腸内環境改善食品
EP3446713A3 (fr) 2012-05-02 2019-05-15 Capsugel Belgium NV Dispersions aqueuses de polymères à libération contrôlée et coques et capsules de celles-ci
JP2014015431A (ja) 2012-07-10 2014-01-30 Nakanihon Capsule Co Ltd ソフトカプセル皮膜及びソフトカプセル
US20140050789A1 (en) 2012-08-13 2014-02-20 The Regents Of The University Of California Mitigation of epileptic seizures by combination therapy using benzodiazepines and neurosteroids
US20150223488A1 (en) * 2012-08-22 2015-08-13 Intercontinental Great Brands Llc Flavor pre-blend of ingredients for chewing gum, methods of making pre-blend ingredients and chewing gum compositions thereof
US9180104B2 (en) 2013-03-13 2015-11-10 Tris Pharma, Inc. Benzonatate modified release solid tablets and capsules
EP2968081A4 (fr) 2013-03-15 2016-08-10 Banner Life Sciences Llc Capsules entériques molles ne contenant pas de gélatine
WO2014152097A1 (fr) 2013-03-15 2014-09-25 Banner Pharmacaps Inc. Capsules à base de soie
CA2997734C (fr) 2013-09-13 2022-01-04 Phood Station Produits alimentaires encapsules et procedes pour les fabriquer
US9504656B2 (en) 2013-10-21 2016-11-29 Banner Life Sciences, LLC Pharmaceutical compositions for poorly soluble active ingredients
GB201319791D0 (en) * 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
GB201319792D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
GB201400442D0 (en) 2014-01-10 2014-02-26 Sigmoid Pharma Ltd Compositions for use in the treatment of ulcerative colitis
JP6292938B2 (ja) 2014-03-27 2018-03-14 中日本カプセル 株式会社 ソフトカプセル皮膜及びソフトカプセル
CN103893771B (zh) 2014-04-21 2015-08-26 湖南尔康制药股份有限公司 一种用于生产淀粉材料软胶囊的成膜组合物及其制备方法
US20150335586A1 (en) * 2014-05-20 2015-11-26 R.P. Scherer Technologies, Llc Capsule dispensing container
US20150342893A1 (en) * 2014-05-29 2015-12-03 Sigmoid Pharma Limited Celecoxib formulations useful for treating colorectal cancer
WO2015195989A1 (fr) 2014-06-20 2015-12-23 Banner Life Sciences Llc Compositions de capsules entériques molles
US20150366814A1 (en) 2014-06-23 2015-12-24 Banner Life Sciences Llc All-natural enteric soft capsules comprising active ingredients
US9895333B2 (en) 2014-06-26 2018-02-20 Patheon Softgels Inc. Enhanced bioavailability of polyunsaturated fatty acids
WO2016044805A1 (fr) 2014-09-18 2016-03-24 Virun, Inc. Compositions de gel mou et concentrés pré-gel
CA2960631C (fr) 2014-10-06 2018-06-05 Fuji Capsule Co., Ltd. Methode de fabrication de capsule souple enterique
KR101607459B1 (ko) * 2015-02-02 2016-03-31 코스맥스바이오 주식회사 장용성 연질캡슐용 피막매스 조성물
WO2016140933A2 (fr) 2015-03-02 2016-09-09 Bionpharma Healthcare Llc Compositions d'ibuprofène solubles à libération immédiate
US9867779B2 (en) * 2015-03-26 2018-01-16 Patheon Softgels Inc. Liquisoft capsules

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130259933A1 (en) * 2012-03-30 2013-10-03 Morishita Jintan Co., Ltd. Capsule which disintegrates specifically in the large intestine
EP3205339A1 (fr) * 2014-10-06 2017-08-16 Fuji Capsule Co., Ltd. Procédé de production de capsules molles sans raccord à enrobage entérique

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
GULLAPALLI RAMPURNA P ET AL: "Gelatin and Non-Gelatin Capsule Dosage Forms", JOURNAL OF PHARMACEUTICAL SCIENCES, ELSEVIER INC, US, vol. 106, no. 6, 31 May 2017 (2017-05-31), pages 1453 - 1465, XP009532727, ISSN: 1520-6017, [retrieved on 20170214], DOI: 10.1016/J.XPHS.2017.02.006 *

Also Published As

Publication number Publication date
WO2019178444A1 (fr) 2019-09-19
JP7303221B2 (ja) 2023-07-04
PH12020500621A1 (en) 2021-03-15
RU2020132992A (ru) 2022-04-15
IL276942A (en) 2020-10-29
EP3768094A1 (fr) 2021-01-27
IL276942B2 (en) 2024-11-01
IL276942B1 (en) 2024-07-01
US20210038526A1 (en) 2021-02-11
EP3768094B1 (fr) 2024-05-01
SG11202008715WA (en) 2020-10-29
MY202587A (en) 2024-05-09
JP2021518429A (ja) 2021-08-02
AU2019236217B2 (en) 2025-02-20
BR112020018277A2 (pt) 2020-12-29
US11980691B2 (en) 2024-05-14
AU2019236217A1 (en) 2020-09-17
EP3768094C0 (fr) 2024-05-01
MX2020008650A (es) 2020-10-15
CN111867399B (zh) 2024-10-29
AR115269A1 (es) 2020-12-16
CA3091686A1 (fr) 2019-09-19
CN111867399A (zh) 2020-10-30
ZA202005153B (en) 2023-12-20

Similar Documents

Publication Publication Date Title
EP3768094A4 (fr) Capsules à enveloppe molle entériques
EP3801694A4 (fr) Injecteur à auto-insertion
CA193547S (fr) Sac à dos
IL280798A (en) Direct enhanced view optic
EP3302192A4 (fr) Four à convection
EP3653203A4 (fr) Capsule entérique dure
EP3479731A4 (fr) Sac à dos interactif
EP3465453A4 (fr) Interface à nombre de broches réduit
EP3837106A4 (fr) Thermographie
EP4051203A4 (fr) Capsule de suppositoire
EP3631348A4 (fr) Projectile à joint unique
MA46858A (fr) Réacteur à fusion
EP3468396A4 (fr) Capsules de mélasse à chicha
EP3533312A4 (fr) Machine autotractée à pousser
EP3452687A4 (fr) Obturateur anti-éruption à large corps de bride
IL276943A (en) Enteric soft gel capsules
EP4389952C0 (fr) Machine à tresser
EP3768623A4 (fr) Ensemble d'alignement
DK3338804T3 (da) Enterisk kapsel
IL279624A (en) Hard capsule for the intestine
EP3742101A4 (fr) Refroidisseur à ébullition
EP3897163A4 (fr) Injecteur à viande
DK3487980T3 (da) Bundt
EP3426046A4 (fr) Four de type à convoyeur
EP3824260A4 (fr) Structure à thermocouple

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20201008

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: R.P. SCHERER TECHNOLOGIES, LLC

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Ipc: A61K0009480000

Ref country code: DE

Ref legal event code: R079

Ref document number: 602019051449

Country of ref document: DE

Free format text: PREVIOUS MAIN CLASS: H99Z9999999999

Ipc: A61K0009480000

A4 Supplementary search report drawn up and despatched

Effective date: 20220127

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/48 20060101AFI20220121BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20230222

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20231116

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602019051449

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

U01 Request for unitary effect filed

Effective date: 20240522

U07 Unitary effect registered

Designated state(s): AT BE BG DE DK EE FI FR IT LT LU LV MT NL PT SE SI

Effective date: 20240603

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240901

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240501

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240802

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240501

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240501

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240501

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240801

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240901

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240501

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240802

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240501

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240801

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240501

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240501

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240501

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240501

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240501

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240501

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240501

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240501

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602019051449

Country of ref document: DE

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20250204

U20 Renewal fee for the european patent with unitary effect paid

Year of fee payment: 7

Effective date: 20250327

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20250401

Year of fee payment: 7

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240501

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20250315

REG Reference to a national code

Ref country code: CH

Ref legal event code: U11

Free format text: ST27 STATUS EVENT CODE: U-0-0-U10-U11 (AS PROVIDED BY THE NATIONAL OFFICE)

Effective date: 20260401

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20260327

Year of fee payment: 8